• No results found

VU Research Portal

N/A
N/A
Protected

Academic year: 2021

Share "VU Research Portal"

Copied!
3
0
0

Bezig met laden.... (Bekijk nu de volledige tekst)

Hele tekst

(1)

VU Research Portal

HPV-based cervical screening

Polman, N.J.

2019

document version

Publisher's PDF, also known as Version of record

Link to publication in VU Research Portal

citation for published version (APA)

Polman, N. J. (2019). HPV-based cervical screening: Challenges and future perspectives.

General rights

Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain

• You may freely distribute the URL identifying the publication in the public portal ?

Take down policy

If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim.

E-mail address:

vuresearchportal.ub@vu.nl

(2)

Contents

Chapter 1 General introduction and thesis outline 9

PART 1: CHALLENGES IN HPV-BASED CERVICAL SCREENING

Chapter 2 Evaluation of the clinical performance of the HPV-Risk assay using the VALGENT-3 panel

45

Journal of Clinical Microbiology 2017; 55(12):3544-3551.

Chapter 3 Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: Baseline and longitudinal data

59

International Journal of Cancer 2015; 136(10):2361-2368.

Chapter 4 Good performance of p16/Ki-67 dual-stained cytology for surveillance of women treated for high-grade CIN

77

International Journal of Cancer 2017; 140(2):423-430.

Chapter 5 HPV-positive women with normal cytology remain at increased risk of CIN3 after a negative repeat HPV test

95

British Journal of Cancer 2017; 117(10):1557-1561.

Chapter 6 Management of HPV-positive women in cervical screening using results from two consecutive screening rounds

109

International Journal of Cancer 2019; 144(9):2339-2346.

Chapter 7 Five-year cervical (pre)cancer risk of women screened by HPV and cytology testing

129

(3)

PART 2: FUTURE PERSPECTIVES IN HPV-BASED CERVICAL SCREENING

Chapter 8 Performance of human papillomavirus testing on self-collected versus clinician-collected samples for the detection of cervical intraepithelial neoplasia of grade 2 or worse: a randomised, paired screen-positive, non-inferiority trial

149

Lancet Oncology 2019; 20(2):229-238.

Chapter 9 Experience with HPV self-sampling and clinician-based sampling in women attending routine cervical screening in the Netherlands

173

Submitted.

Chapter 10 General discussion 193

HPV-based cervical screening: rationale, expectations and future perspectives of the new Dutch screening programme

Preventive Medicine 2019; 119:108-117.

Chapter 11 English summary 221

Nederlandse samenvatting

Chapter 12 List of co-authors 237

Referenties

GERELATEERDE DOCUMENTEN

Evaluation of the long-term reassurance of a low cervical cancer risk in hrHPV-positive women who test negative for p16/Ki-67 dual stained cytology or CADM1/MAL or FAM19A4(/

The results show that HPV-positive women with normal cytology and a negative triage test, either repeat- cytology after 12 months or baseline HPV16/18 genotyping, have a CIN3+ risk

Chapter 4 Triaging HPV-positive women with normal cytology by p16/Ki-67 dual-stained cytology testing: baseline and longitudinal data. Int

analysis show that HPV-positive women with normal cytology and a negative triage test, either repeat cytology after 12 months or baseline HPV16/18 genotyping, develop a

Triaging equivocal cytology of the cervix : identyfying women at risk for high-grade cervical lesions Wensveen, C.W.M.. Triaging equivocal cytology of the cervix : identyfying women

Can viral load, semi-quantitatively evaluated, of human papillomavirus 53 predict cytological or histological outcome in women with atypical. squamous or glandular cells of

Recurrent human papillomavirus infection detected with the hybrid capture II assay selects women with normal cervical smears at risk for developing high grade cervical

Because of this phenomenon we recommend a high risk HPV DNA test of the cervix in women with ASCUS/ AGUS cytology, and if this test is positive a colposcopy with biopsy